Recognition and epileptology of protracted CLN3 disease
Epilepsia · 2023
DOI: 10.1111/epi.17616 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, 2023. Verfasst von Jillian M Cameron und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Epilepsy Research Centre, University of Melbourne, Austin Health, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Neuronal Ceroid-Lipofuscinoses, Epilepsy, Generalized. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council.
Abstract (Originalsprache)
Objective
This study was undertaken to analyze phenotypic features of a cohort of patients with protracted CLN3 disease to improve recognition of the disorder.
Methods
We analyzed phenotypic data of 10 patients from six families with protracted CLN3 disease. Haplotype analysis was performed in three reportedly unrelated families.
Results
Visual impairment was the initial symptom, with onset at 5–9 years, similar to classic CLN3 disease. Mean time from onset of visual impairment to seizures was 12 years (range = 6–41 years). Various seizure types were reported, most commonly generalized tonic–clonic seizures; focal seizures were present in four patients. Progressive myoclonus epilepsy was not seen. Interictal electroencephalogram revealed mild background slowing and 2.5–3.5‐Hz spontaneous generalized spike–wave discharges. Additional interictal focal epileptiform discharges were noted in some patients. Age at death for the three deceased patients was 31, 31, and 52 years. Molecular testing revealed five individuals were homozygous for c.461‐280_677 + 382del966, the "common 1‐kb" CLN3 deletion. The remaining individuals were compound heterozygous for various combinations of recurrent pathogenic CLN3 variants. Haplotype analysis demonstrated evidence of a common founder for the common 1‐kb deletion. Dating analysis suggested the deletion arose approximately 1500 years ago and thus did not represent cryptic familial relationship in this Australian cohort. Significance We highlight the protracted phenotype of a disease generally associated with death in adolescence, which is a combined focal and generalized epilepsy syndrome with progressive neurological deterioration. The disorder should be suspected in an adolescent or adult patient presenting with generalized or focal seizures preceded by progressive visual loss. The common 1‐kb deletion has been typically associated with classic CLN3 disease, and the protracted phenotype has not previously been reported with this genotype. This suggests that modifying genetic factors may be important in determining this somewhat milder phenotype and identification of these factors should be the subject of future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Epilepsy Research Centre, University of Melbourne, Austin Health, Melbourne, Victoria, Australia.
- Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia.
- Florey Institute of Neuroscience and Mental Health, Heidelberg, Victoria, Australia.
- Department of Pathology, St Vincent's Hospital Melbourne, Melbourne, Victoria, Australia.
- Department of Medicine, University of Western Australia, Perth, Western Australia, Australia.
- Royal Perth Hospital, Perth, Western Australia, Australia.
ORCID-Profile: Bronwyn Grinton, Ingrid E Scheffer, Karen L Oliver, Samuel F Berkovic
Förderung
- National Health and Medical Research Council
Zitieren
APA
Cameron, J. M., Damiano, J. A., Grinton, B., Carney, P. W., McKelvie, P., Silbert, P., Lawn, N., Scheffer, I. E., Oliver, K. L., Hildebrand, M. S., & Berkovic, S. F. (2023). Recognition and epileptology of protracted CLN3 disease. Epilepsia. https://doi.org/10.1111/epi.17616
Vancouver
Cameron JM, Damiano JA, Grinton B, Carney PW, McKelvie P, Silbert P, et al. Recognition and epileptology of protracted CLN3 disease. Epilepsia. 2023. doi:10.1111/epi.17616
BibTeX
@article{Cameron2023,
author = {Cameron, Jillian M and Damiano, John A and Grinton, Bronwyn and Carney, Patrick W and McKelvie, Penny and Silbert, Peter and Lawn, Nicholas and Scheffer, Ingrid E and Oliver, Karen L and Hildebrand, Michael S and Berkovic, Samuel F},
title = {Recognition and epileptology of protracted CLN3 disease},
journal = {Epilepsia},
year = {2023},
doi = {10.1111/epi.17616}
}
EUVIMED